Compugen reports Q2 2026 results, cash runway extended into 2029
MAIA-ovarian interim data still expected by Q1 2027 as partnered programs advance and net loss narrows to $7.0 million.
SEC filing
1 story
MAIA-ovarian interim data still expected by Q1 2027 as partnered programs advance and net loss narrows to $7.0 million.
SEC filing